SEC Form D · Amendment · filed January 28, 2020
Amylyx Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Justin Klee · Cambridge, MAExec · DirectorWalter Gilbert · Cambridge, MADirectorGeorge Milne · Cambridge, MADirectorPeter B. Finn · Boston, MAExecIsaac Cheng · Cambridge, MADirectorStephen Chubb · Cambridge, MADirectorJoshua Cohen · Cambridge, MAExec · DirectorFelix Von Coerper · Cambridge, MADirectorBethany A. Uhlein · Rye, NYDirectorJohn C. Ball · Rye, NYExec · DirectorKuni C. Nakamura · Rye, NYDirectorAnthonie C. Van Ekris · Rye, NYDirectorStephen Chubb · Cambridge, MADirectorRobert C. Kolodny · Rye, NYDirectorBruce N. Alpert · Rye, NYExec · DirectorEric M. Siegal · CHICAGO, ILExecDaniel M. Rosenbloom · CHICAGO, ILExecBenjamin Siegel · NEW YORK, NYExec · DirectorRobert N. Crimmins · Seattle, WAExec · DirectorRex Antinozzi · Traverse City, MIDirectorApurva Mehta · FORT WORTH, TXDirectorPatrick O'Connor · FORT WORTH, TXDirectorAnthony M. Scaramucci · New York, NYDirectorBrett S. Messing · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗